In comparison, the GCB subtype DLBCL follows a “tonic” BCR signaling pathway that is antigen-independent, mediated by PI3k/AKT/mTOR pathway, and lacks NF-κB pathway activity [28]. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.